Langen KJ - Search Results

1

3-[123I]iodo-alpha-methyltyrosine and [methyl-11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET.

Langen KJ, Ziemons K, Kiwit JC, Herzog H, Kuwert T, Bock WJ, Stöcklin G, Feinendegen LE, Müller-Gärtner HW. Langen KJ, et al. J Nucl Med. 1997 Apr;38(4):517-22. J Nucl Med. 1997. PMID: 9098193 Free article.

2

On the influence of spatial resolution and of the size and form of regions of interest on the measurement of regional cerebral metabolic rates by positron emission tomography.

Kuwert T, Sures T, Herzog H, Loken M, Hennerici M, Langen KJ, Feinendegen LE. Kuwert T, et al. Among authors: langen kj. J Neural Transm Suppl. 1992;37:53-66. doi: 10.1007/978-3-7091-9209-2_5. J Neural Transm Suppl. 1992. PMID: 1402852 Review.

3

Brain and brain tumor uptake of L-3-[123I]iodo-alpha-methyl tyrosine: competition with natural L-amino acids.

Langen KJ, Roosen N, Coenen HH, Kuikka JT, Kuwert T, Herzog H, Stöcklin G, Feinendegen LE. Langen KJ, et al. J Nucl Med. 1991 Jun;32(6):1225-9. J Nucl Med. 1991. PMID: 2045937 Free article.

4

SPECT studies of brain tumors with L-3-[123I] iodo-alpha-methyl tyrosine: comparison with PET, 124IMT and first clinical results.

Langen KJ, Coenen HH, Roosen N, Kling P, Muzik O, Herzog H, Kuwert T, Stöcklin G, Feinendegen LE. Langen KJ, et al. J Nucl Med. 1990 Mar;31(3):281-6. J Nucl Med. 1990. PMID: 2155314 Free article.

5

Quantification of the whole-body distribution of PET radiopharmaceuticals, applied to 3-N-([18F]fluoroethyl)spiperone.

Herzog H, Coenen HH, Kuwert T, Langen KJ, Feinendegen LE. Herzog H, et al. Among authors: langen kj. Eur J Nucl Med. 1990;16(2):77-83. doi: 10.1007/BF01465913. Eur J Nucl Med. 1990. PMID: 2311622

6

Early effects of intra-arterial chemotherapy in patients with brain tumours studied with PET: preliminary results.

Langen KJ, Roosen N, Kuwert T, Herzog H, Kiwit JC, Rota Kops E, Muzik O, Bock WJ, Feinendegen LE. Langen KJ, et al. Nucl Med Commun. 1989 Nov;10(11):779-90. doi: 10.1097/00006231-198911000-00002. Nucl Med Commun. 1989. PMID: 2557570

7

Investigations of brain tumours with 99Tcm-HMPAO SPECT.

Langen KJ, Roosen N, Herzog H, Kuwert T, Kiwit JC, Bock WJ, Feinendegen LE. Langen KJ, et al. Nucl Med Commun. 1989 May;10(5):325-34. doi: 10.1097/00006231-198905000-00003. Nucl Med Commun. 1989. PMID: 2787007

8

Tomographic studies of rCBF with [99mTc]-HM-PAO SPECT in patients with brain tumors: comparison with C15O2 continuous inhalation technique and PET.

Langen KJ, Herzog H, Kuwert T, Roosen N, Rota E, Kiwit JC, Bock WJ, Feinendegen LE. Langen KJ, et al. J Cereb Blood Flow Metab. 1988 Dec;8(6):S90-4. doi: 10.1038/jcbfm.1988.37. J Cereb Blood Flow Metab. 1988. PMID: 2848045

9

Tomographic studies of rCBF with 99mTc-HM-PAO SPECT in comparison with PET in patients with primary brain tumors.

Langen KJ, Herzog H, Rota E, Roosen N, Wieler H, Kiwit J, Kuwert T, Storch-Becker A, Feinendegen L. Langen KJ, et al. Neurosurg Rev. 1987;10(1):23-4. doi: 10.1007/BF01780589. Neurosurg Rev. 1987. PMID: 3499584

10

SPECT with HMPAO compared to PET with FDG in Huntington disease.

Boecker H, Kuwert T, Langen KJ, Lange HW, Czech N, Ziemons K, Herzog H, Shikare S, Weindl A, Feinendegen LE. Boecker H, et al. Among authors: langen kj. J Comput Assist Tomogr. 1994 Jul-Aug;18(4):542-8. doi: 10.1097/00004728-199407000-00005. J Comput Assist Tomogr. 1994. PMID: 8040434

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

328 results

Search Page

Filters